Detecting complications early after GI surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study watches how your body's recovery signs change after major gastrointestinal surgery, to catch problems early and improve your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having a planned or urgent major surgery on your stomach or intestines.
- Your doctors will have enough follow-up data and blood test results to track your recovery patterns.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks blood and other lab “biomarkers” during the time before and after major surgeries to see if they can help guide perioperative care. You might be eligible if you are having certain planned heart, lung, GI, or blood-vessel surgeries and can give informed consent.
This study looks for ways to better predict and catch infections after major abdominal cancer surgery. If you are having surgery for certain cancers (esophagus, stomach, pancreas, liver, bile ducts, colon, or rectum), the researchers will check your blood and other samples for early signs of infection so they can start treatment sooner.
This study looks at proteins and body measurements to predict complications after colorectal cancer surgery. It may help doctors take better care of you after your operation.
This study looks at colorectal cancer patients who are planning curative surgery and collects related outcomes and lab “biomarker” information to better understand the disease. Your participation may help researchers connect test results to treatment results over time.
This trial tests a smart monitoring system to watch for complications after major cancer surgery. It may help doctors catch problems early so you can recover better.
This study watches for signs of leftover cancer after surgery using a blood test (MRD). It is for people with early-stage colon cancer who have not yet had any treatment other than surgery.
Hear when a new Oncologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.